Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q4 2023 Earnings Call Transcript
Adaptive Biotechnologies Corporation beats earnings expectations. Reported EPS is $-0.3, expectations were $-0.32.
Adaptive Biotechnologies Corp (ADPT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | ARK Investment Management Catherine D. Wood | 10,561,296 | $33,901,759 | -18% | 0.23% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $20.00 | 2,500 | Officer | 2,500 | 2019-07-01 | Filing | |
| $20.00 | 1,000 | Officer | 1,000 | 2019-07-01 | Filing | |
| $20.00 | 300 | Officer | 300 | 2019-07-01 | Filing | |
| $20.00 | 400 | Officer | 400 | 2019-07-01 | Filing | |
| $20.00 | 500 | Officer | 500 | 2019-07-01 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.43 | 7,727 | Officer | 123,318 | 2024-03-05 | Filing | |
| $3.44 | 6,609 | Officer | 166,287 | 2024-03-05 | Filing | |
| $3.43 | 6,772 | Officer | 172,896 | 2024-03-05 | Filing | |
| $3.44 | 1,813 | Officer | 253,745 | 2024-03-05 | Filing | |
| $3.43 | 12,887 | Officer | 255,558 | 2024-03-05 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 12,767,684 | $62,561,652 | 0% | |
| 2. | 11,421,554 | $55,965,614 | 0% | |
| 3. | 6,511,659 | $31,907,129 | 0.3% | |
| 4. | 6,511,659 | $31,907,129 | 0.02% | |
| 5. | 3,422,356 | $16,769,544 | 0.01% |
News See All
Here’s Why Adaptive Biotechnologies Corporation (ADPT) Declined in Q4
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Focus Growth Strategy” fourth quarter 2023 investor letter. A copy of the same can be downloaded here.
16 Best Penny Stocks To Buy For 2024
The stock market’s optimism wave recently saw a break after latest data showed that the US labor market remains resilient despite consistent rate hikes to curb inflation.
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q3 2023 Earnings Call Transcript
Operator: Thank you for standing by. At this time, I would like to welcome everyone to today’s Adaptive Biotechnologies 2023 Third Quarter Earnings Call.
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q2 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies Second Quarter 2023 Conference Call. At this time, all participants are in a listen-only mode.
Is it Still Worthy to Invest in Adaptive Biotechnologies (ADPT)?
Aristotle Atlantic Partners, an investment management firm, released its second quarter 2023 investor letter, a copy of which can be downloaded here.
Viking Global's Performance, AUM, and Long-Term Stock Picks
In this article, we discuss Viking Global's performance, AUM, and 10 long-term stock picks.
11 Best Medical Stocks Under $10
In this piece, we will take a look at the eleven best medical stocks under $10.
Adaptive Biotechnologies Corporation (NASDAQ:ADPT) Q1 2023 Earnings Call Transcript
Operator: Good day, and thank you for standing by. Welcome to the Adaptive Biotechnologies First Quarter 2023 Conference Call.
11 Most Promising Gene Editing Stocks According to Analysts
In this article, we will take a look at the 11 most promising gene editing stocks according to analysts.